期刊文献+

Graves病小鼠模型IL-10水平与Th17细胞功能的检测和意义 被引量:1

Determination of Th17 cellular function and IL-10 in the mice of experimental Graves disease model
下载PDF
导出
摘要 目的研究Th17细胞及相关细胞因子IL-17 mRNA与IL-10 mRNA在实验性Graves小鼠体内变化。方法利用TSHR-E(胞外区)的腺病毒免疫小鼠方法建立Graves疾病模型,化学发光法检测血清FT4水平,细胞培养生物学方法检测TSAb活性,流式细胞术(FCM)分析小鼠脾脏细胞中Th17细胞的比例,qRT-PCR检测小鼠脾脏细胞中IL-17和IL-10mRNA水平。结果小鼠血清FT4及TSAb水平升高,TSAb与FT4水平呈显著正相关(r=0.90,P<0.01);Graves小鼠脾细胞中Th17细胞的比例为(2.56±0.43)%,明显高于正常对照组小鼠(1.07±0.27%)%(P<0.05);Graves小鼠脾细胞中IL-17 mRNA的含量明显高于正常对照组(P<0.05),而IL-10 mRNA的含量明显低于正常对照组(P<0.05);且IL-17和IL-10水平变化存在明显的负相关(r=-0.564,P<0.01)。结论 TSHR-E(胞外区)的腺病毒免疫建立的GD模型中,IL-17mRNA增加和IL-10 mRNA则明显下降;提示两者可能在GD的发生及发展中发挥免疫调节作用。 Objective To study the change of Thl7 cells, IL-17 mRNA and IL-10 mRNA in mice of experimental Graves disease (GD). Methods Mouse model of Grave disease was immunized with Ad-TSHR-E. Serum free T4 concentrations were deter- mined by chemiluminescent immunoassay, and serum thyroid stimulating antibodies (TSAb) were determined by cell culture bio- method. The percentages of Thl7 cells in spleens were determined by flow cytometry. Expression of IL-17 mRNA and IL-10 mRNA in spleen were measured by Real-time RT-PCR. Results Serum free T4 concentrations and anti-TSHR antibodies were increased. There was a positive correlation between serum TSAb values and FF4 levels (r=0.90, P 〈 0.01 ). The percentage of Thl7 cells in spleens of the GD group (2.56±0.43) % was higher than that in the control group ( 1.07 ±0.27 ) % (P〈0.05). The level of IL- 10 mRNA expression in spleen from GD mice decreased significantly(P〈0.05). On the contrary, IL-17 mRNA expression increased markedly (P〈0.05). There was a negative correlation between amount of IL-10 and IL-17 mRNA(r=-0.564,P〈0.01 ). Conclusion The ex- pression of IL-17 was increased and IL-10 mRNA expression decreased in the mice GD model. Those results suggest that IL-17 and II-10 may play an immune regulatory role in the occurrence and development of GD.
出处 《解剖学研究》 CAS 2012年第6期424-427,共4页 Anatomy Research
基金 广东省大学生创新实验项目(1057310016)
关键词 GRAVES病 白细胞介素10 白细胞介素17 Th17细胞 Graves disease Thl7 cells Interleukin- 10 Interleukin-17
  • 相关文献

参考文献12

  • 1Zhu S, Qian Y. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin Sci (Lond), 2012,122(11) :487-511.
  • 2NicteFV, Manuel AP, Ignacio B, et al. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol & Metabolism, 2010,95 (2) : 953-962.
  • 3Ueki I, Abiru N, Kawagoe K, et al. Interleukin 10 deficiency attenuates induction of anti-TSH receptor antibodies and hyperthyroidism in a mouse Graves' model. Journal of Endocrinology, 2011, 209( 1 ) : 353-357.
  • 4Saitoh O, Mizutori Y, Takamura N, et al. Adenovirus- mediated gene delivery of interleukin-10, but not transforming growth factor 6, ameliorates the induction of Graves'hyperthyroidism in BALB/c mice. Clinical and Experimental Immunology, 2005,141 (2) : 405-411.
  • 5Wilke CM, Wang L, Wei S, et al. Endogenous interleukin-10 constrains Th17 cells in patients with inflammatory bowel disease. Journal of Translational Medicine, 2011,9(1) :217-230.
  • 6Inaba H, Pan D, Shin Y, et al. Immune response of mice transgenic for human histocompatibity leukocyte antigen- DR to human thyeotopin receptor-extracellular domain. Thyroid, 2009,19( 11 ) : 1271-1280.
  • 7Kim SE, Yoon JS, Kim KH, et al. Increased serum interleukin-17 in Graves' ophthalmopathy. Graefes Arch Clin Exp Ophthalmol, 2012 Jul 1. [Epub ahead of print].
  • 8Asadullah K, Sterry W, Volk HD. Interleukin-10 therapyreview of a new approach. Pharmacological Reviews, 2003,55 ( 1 ) : 241-269.
  • 9Batteux F, Trebeden H, Charreire J , et al. Curative treatment of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for interleukin- 10. European Journal of Immunology, 1999,29 (2) : 958- 963.
  • 10Zhang GX, Xiao BG, Yu LY, et al. Interleukin 10 aggravates experimental autoimmune myasthenia gravis throughinducing Th2 and B cell responses to AChR. Journal of Neuroimmunology, 2001,113 (1) : 10-18.

同被引文献38

  • 1Numasaki M, Watanabe M, Suzuki T, et al. IL-17 en- hances the net angiogenic activity and in vivo growth of hu- man non-small cell lung cancer in SCID mice through pro- moting CXCR-2-dependent angiogenesis. J Immunol, 2005, 175:6177-6189.
  • 2Numasaki M, Fukushi J, Ono M, et al. Interleukin-17 pro- motes angiogenesis and tumor growth. Blood, 2003, 101: 2620-2627.
  • 3Ye ZJ, Zhou Q, Gu , et al. Generation and differentia- tion of IL-17- producing CD4 cells in malignant pleural ef- fusion. J Immunol, 2010,185(10) : 6348-6354.
  • 4Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature, 2000,407 : 249-257.
  • 5Kryczek I, Lange A, Mottram P, et al. CXCL12 and vascu- lar endothelial growth factor synergistically induce neoangio- genesis in human ovarian cancers. Cancer Res, 2005,65: 465-472.
  • 6Kryczek I, Banerjee M, Cheng P, et al. Phenotype, distri- bution, generation, and functional and clinical relevance of Thl7 cells in the human tumor environments. Blood, 2009, 114(6):1141-1149.
  • 7Hue S, Ahem P, Buonocore S, et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med, 2006,203 : 2473-2483.
  • 8Overwijk WW, De Visser KE, Tirion FH, et al. Immuno- logical and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol , 2006, 76:5213-5222.
  • 9Hu J, Yuan X, Belladonna ML, et al. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic ceils. Cancer Res, 2006,66:8887- 8896.
  • 10Sfanos KS, Bruno TC, Maris CH, et al. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res, 2008,14: 3254-3261.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部